Vascular and Metabolic Effects of Rosuvastatin

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 160 participants.

Also called NCT01660919

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01660919
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01660919. Randomized; single masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2013-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vascular and Metabolic Effects of Rosuvastatin
Condition
Hypercholesterolemia
Intervention (Drug)
placebo
Intervention (Drug)
rosuvastatin
Lead sponsor
Gachon University Gil Medical Center (class: other)

Record details

Record id
cardio:ct-nct01660919
Content hash
4022db64f74af6439f90ab528439464351d9df563062f632b7f4525a9de85adf